April 30, 2019
FDA: Class I recall of Miller and Fogarty Atrioseptostomy Dilation Catheters
Editor's Note
The Food & Drug Administration (FDA) on April 26 identified the recall of Edwards Lifesciences' Miller and Fogarty Atrioseptostomy Dilation Catheters as Class I, the most serious.
The recall was initiated because of reports of difficulty in balloon deflation after deployment, which may lead to balloon fragmentation or detachment on retrieval.
The catheters are used to enlarge the opening between the two upper chambers (atria) of the heart.
Free Daily News
- Review on pneumatic tourniquet safety
- Coronary computed tomography angiography helps predict first coronary events
- Environment influences OR team performance
- Ambulatory shift transforming care models for high-acuity patients
- How to improve outpatient first case starts
- Engage anesthesia group to expand volume
- Ethical considerations for deploying AI in surgery
- BMI a valuable metric in THA surgical planning, risk stratification
- Surgical discharge against medical advice on the rise
- Liberal blood transfusion doesn’t reduce poor outcomes in high cardiac risk patients
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement